A Rational Policy for Measuring and Lowering Cholesterol

Martin MJ Hulley SB Browner WS Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361 662 men. Lancet 1986; ii: 933–36.

Neaton JD Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Arch Intern Med 1992; 152: 56–64.

Royal College of General Practitioners. Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Occasional Paper 55. London: Royal College of General Practitioners, 1992: 1–15.

International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: Scientific background and new clinical guidelines. Recommendations of the European Athersclerosis Society. Nutr Metab Cardiovasc Dis 1992; 2: 113–56.

Betteridge DJ Dodson PM Durrington PN Management of hyperlipidaemia: Guidelines of the British Hyperlipidaemia Association. Postgrad Med J 1993; 69: 359–69.

Kannel WB Neaton JD Wentworth D Overall and coronary heart disease mortality rates in relation to major risk factors in 325 348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J 1986; 112: 825–36.

Tunstall-Pedoe H Smith WCS Tavendale R. How-often-that-high graphs of serum cholesterol. Findings from the Scottish Heart Health and Scottish MONICA Studies. Lancet 1989; i: 540–42.

Tyroler HA . Overview of clinical trials of cholesterol lowering in relationship to epidemiologic studies. Am J Med 1989; 87 (suppl 4A): 14S–19S.

Law MR Wald NJ Thompson SG . By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 1994; 308: 367–72.

Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–89.

Ramsay LE Yeo WW Jackson PR . Dietary reduction if serum cholesterol concentration: Time to think again. Br Med J 1991; 303: 953–57.

Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982; 248: 1465–77.

Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: Principal results of British family heart study. Br Med J 1994; 308: 313–20.

Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: Results of the OXCHECK study after one year. Br Med J 1994; 308: 308–12.

Cupples ME McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. Br Med J 1994; 309: 993–96.

Expert Panel . Second report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994; 89: 1329–445.

Hunninghake DB Stein EA Dujovne CA The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med 1993; 328: 1213–19.

National Cholesterol Education Program Expert Panel. Report of the National Cholesterol Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36–69.

Pyörälä K De Backer G Graham I Poole-Wilson P Wood D on behalf of the Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–31.

Hjermann I. Smoking and diet intervention in healthy coronary high risk men. Methods and 5-year follow-up of risk factors in a randomized trial. The Oslo Study. J Oslo City Hosp 1980; 30: 3–17.

Hjermann I Byre Velve K Holme I Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomized trial in healthy men. Lancet 1981; ii: 1303–10.

Smith Davey G Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? Br Med J 1992; 304: 431–34.

Watts GF Lewis B Brunt JNH Effects of coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992; 339: 563–69.

Ramsay LE Yeo WW Jackson PR . Coronary atheroma regression trials. Lancet 1992; 339: 1241–42.

Rivellese AA Auletta P Marotta G Long term metabolic effects of two dietary methods of treating hyperlipidaemia. Br Med J 1994; 308: 227–31.

Ramsay LE Yeo WW Jackson PR . Ischaemic heart disease and cholesterol. Effective diets are unpalatable. Br Med J 1994; 308: 1038–39.

Haq IU Yeo WW Jackson PR Ramsay LE . Diets, HMG-CoA reductase inhibitors and target cholesterol in hypercholesterolaemic subjects [Abstract]. Br J Clin Pharmacol 1994; 39: 545.

Muldoon MF Manuck SB Matthews KA . Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. Br Med J 1990; 301: 309–14.

Ravnskov U. Cholesterol lowering trials in coronary heart disease: Frequency of citation and outcome. Br Med J 1992; 305: 15–19.

Law MR Thompson SG Wald NJ . Assessing possible hazards of reducing serum cholesterol. Br Med J 1994; 308: 373–79.

Law MR Wald NJ . Commentary on the cholesterol papers. Disagreements are not substantial. Br Med J 1994; 308: 1027–29.

Oliver MF . Might treatment of hypercholesterolaemia increase non-cardiac mortality? Lancet 1991; 337: 1529–31.

Smith Davey G Egger M. Commentary on the cholesterol papers. Statistical problems. Br Med J 1994; 308: 1025–27.

Smith Davey G Song F Sheldon TA . Cholesterol lowering and mortality: The importance of considering initial level of risk. Br Med J 1993; 306: 1367–73.

Ravnskov U. Ischaemic heart disease and cholesterol. Optimism about drug treatment is unjustified. Br Med J 1994; 308: 1038.

Stamler J Wentworth D Neaton JD . Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? JAMA 1986; 256: 2823–28.

Shaper AG Pocock SJ Phillips AN Walker N. Identifying men at high risk of heart attacks: Strategy for use in general practice. Br Med J 1986; 293: 474–79.

Rose G Tunstall-Pedoe HD Heller RF . UK Heart Disease Prevention Project: Incidence and mortality results. Lancet 1983; i: 1062–66.

Rose G Heller RF Tunstall-Pedoe H Christie DGS . Heart disease prevention project: A randomised controlled trial in industry. Br Med J 1980; 1: 747–51.

World Health Organization European Colloborative Group. European collaborative trial of multifractorial prevention of coronary heart disease: Final report on the 6-year results. Lancet 1986; i: 869–72.

World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. Risk factor changes at two and four years. Eur Heart J 1982; 3: 184–90.

Burr ML Fehily AM Gilbert JF Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989; ii: 757–61.

Curzio JL Kennedy SS Elliott HL Hypercholesterolaemia in treated hypertensives: A controlled trial of intensive dietary advice. J Hypertens 1989; 7 (suppl 6): S254–S255.

Puska P Salonen JT Nissinen A Changes in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J 1983; 287: 1840–44.

Farquar JW Fortmann SP Flora JA Effects of community wide education on cardiovascular disease risk factors. The Stanford five-city project. JAMA 1990; 264: 359–65.

Wilhelmsen L Berglund G Elmfeldt D The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986; 7: 279–88.

Leren P. The effects of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Med Scand Suppl 1966; 466: 1–92.

Research Committee to the Medical Research Council. Controlled trial of soya-bean oil in myocardial infarction. Lancet 1968; ii: 693–700.

Research Committee. Low-fat diet in myocardial infarction. A controlled trial. Lancet 1965; ii: 501–504.

Rose GA Thomson WB Williams RT . Corn oil in treatment of ischaemic heart disease. Lancet 1965; i: 1531–33.

Frantz ID Dawson EA Ashman PL Test of effect of lipid lowering by diet on cardiovascular risk. The Minnestoa Coronary Survey. Arteriosclerosis 1989; 9: 129–35.

Turpeinen O Karvonen MJ Pekkarinen M Miettinen M Elosuo R Paavilainen E. Dietary prevention of coronary heart disease: The Finnish Mental Hospital Study. In J Epidemiol 1979; 8: 99–118.

Dayton S Pearce ML Goldman H Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet 1968; ii: 1060–62.